aprepitant

Generic: aprepitant

Labeler: bluepoint laboratories
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name aprepitant
Generic Name aprepitant
Labeler bluepoint laboratories
Dosage Form KIT
Manufacturer
BluePoint Laboratories

Identifiers & Regulatory

Product NDC 68001-669
Product ID 68001-669_4496621d-8b64-8aae-e063-6294a90a95e9
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA207777
Listing Expiration 2026-12-31
Marketing Start 2025-12-01

Pharmacologic Class

Established (EPC)
substance p/neurokinin-1 receptor antagonist [epc]
Mechanism of Action
neurokinin 1 antagonists [moa] cytochrome p450 3a4 inhibitors [moa] cytochrome p450 2c9 inducers [moa] cytochrome p450 3a4 inducers [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 68001669
Hyphenated Format 68001-669

Supplemental Identifiers

RxCUI
403810 403811 644088 754508
UPC
0368001669153
UNII
1NF15YR6UY
NUI
N0000010262 N0000175786 N0000182141 N0000185507 N0000185506

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name aprepitant (source: ndc)
Generic Name aprepitant (source: ndc)
Application Number ANDA207777 (source: ndc)
Routes
oral
source: label

Resolved Composition

Strengths
  • 40 mg
  • 80 mg
  • 125 mg
  • 1 unit
  • 6 unit
  • 44 unit
  • 125 mg/80 mg
source: label
Packaging
  • 1 KIT in 1 DOSE PACK (68001-669-15) * 2 CAPSULE in 1 BLISTER PACK * 1 CAPSULE in 1 BLISTER PACK
source: ndc

Packages (1)

68001-669-15 1 KIT in 1 DOSE PACK (68001-669-15) * 2 CAPSULE in 1 BLISTER PACK * 1 CAPSULE in 1 BLISTER PACK

Ingredients (0)

No ingredient records.

Linked Drug Pages (1)

Aprepitant ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"spl_id": "4496621d-8b64-8aae-e063-6294a90a95e9", "openfda": {"nui": ["N0000010262", "N0000175786", "N0000182141", "N0000185507", "N0000185506"], "upc": ["0368001669153"], "unii": ["1NF15YR6UY"], "rxcui": ["403810", "403811", "644088", "754508"], "spl_set_id": ["a78aaa00-a46b-4f9e-a415-2fca9e9a4fb4"], "pharm_class_epc": ["Substance P/Neurokinin-1 Receptor Antagonist [EPC]"], "pharm_class_moa": ["Neurokinin 1 Antagonists [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "Cytochrome P450 2C9 Inducers [MoA]", "Cytochrome P450 3A4 Inducers [MoA]"], "manufacturer_name": ["BluePoint Laboratories"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 KIT in 1 DOSE PACK (68001-669-15)  *  2 CAPSULE in 1 BLISTER PACK *  1 CAPSULE in 1 BLISTER PACK", "package_ndc": "68001-669-15", "marketing_start_date": "20251201"}], "brand_name": "Aprepitant", "product_id": "68001-669_4496621d-8b64-8aae-e063-6294a90a95e9", "dosage_form": "KIT", "product_ndc": "68001-669", "generic_name": "Aprepitant", "labeler_name": "BluePoint Laboratories", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Aprepitant", "application_number": "ANDA207777", "marketing_category": "ANDA", "marketing_start_date": "20251201", "listing_expiration_date": "20261231"}